Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. [electronic resource]
Producer: 20031110Description: 951-60 p. digitalISSN:- 0306-4522
- Analysis of Variance
- Angiogenesis Inducing Agents -- administration & dosage
- Angiogenesis Inhibitors -- administration & dosage
- Angiostatins
- Animals
- Animals, Newborn
- Antigens -- metabolism
- Astrocytes
- Behavior, Animal -- drug effects
- Blood Vessels -- metabolism
- Bromodeoxyuridine -- pharmacokinetics
- Cell Count
- Cell Death
- Cell Division -- drug effects
- Cerebral Cortex -- metabolism
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Endothelial Growth Factors -- genetics
- Extracellular Matrix Proteins -- metabolism
- Female
- Gene Expression Regulation
- Glial Fibrillary Acidic Protein -- metabolism
- Humans
- Immunohistochemistry
- In Situ Hybridization
- In Situ Nick-End Labeling
- Indoles -- metabolism
- Intercellular Signaling Peptides and Proteins -- genetics
- Lymphokines -- genetics
- Nerve Degeneration -- drug therapy
- Neurofilament Proteins -- metabolism
- Neuropilin-1 -- genetics
- Neuropilin-2 -- genetics
- Peptide Fragments -- administration & dosage
- Plasminogen -- administration & dosage
- RNA, Messenger -- metabolism
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Recovery of Function -- physiology
- Spinal Cord -- cytology
- Spinal Cord Injuries -- drug therapy
- Time Factors
- Treatment Outcome
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor Receptor-1
- Vascular Endothelial Growth Factors
- Wound Healing
- von Willebrand Factor -- immunology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.